The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 18, 2020

Filed:

Dec. 18, 2015
Applicant:

G-treebnt Co., Ltd., Seongnam-si, Gyeonggi-do, KR;

Inventors:

Si Young Lee, Ansan-si, KR;

Sin Wook Kang, Seongnam-si, KR;

Ji Hye Sung, Seoul, KR;

Tae Heum Um, Seoul, KR;

Assignee:

G-TREEBNT CO., LTD., Seongnam-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 9/08 (2006.01); C01B 23/00 (2006.01); A61J 1/14 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61J 1/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/08 (2013.01); A61J 1/1468 (2015.05); A61K 9/0048 (2013.01); A61K 38/22 (2013.01); A61K 38/2292 (2013.01); A61K 47/02 (2013.01); C01B 23/00 (2013.01); A61J 1/12 (2013.01);
Abstract

The present invention relates to a method for manufacturing an ophthalmic preparation comprising thymosin β4. According to the inventive method, the manufacture of an ophthalmic preparation comprising thymosin β4 is carried out in the presence of an inert gas, thus the contact of thymosin β4 with oxygen is blocked and the oxidation of thymosin β4 can be prevented and the pharmacological activity of thymosin β4 maintains for long-term period. Therefore, the ophthalmic preparation prepared by the inventive method can maintain the pharmacological activity of thymosin β4 in a stable state for a long time.


Find Patent Forward Citations

Loading…